Transporters at CNS barrier sites: Obstacles or opportunities for drug delivery?

Lucy Sanchez-Covarrubias, Lauren M. Slosky, Brandon J. Thompson, Thomas P. Davis, Patrick T. Ronaldson

Research output: Contribution to journalReview articlepeer-review

196 Scopus citations


The blood-brain barrier (BBB) and blood-cerebrospinal fluid (BCSF) barriers are critical determinants of CNS homeostasis. Additionally, the BBB and BCSF barriers are formidable obstacles to effective CNS drug delivery. These brain barrier sites express putative influx and efflux transporters that precisely control permeation of circulating solutes including drugs. The study of transporters has enabled a shift away from "brute force" approaches to delivering drugs by physically circumventing brain barriers towards chemical approaches that can target specific compounds of the BBB and/or BCSF barrier. However, our understanding of transporters at the BBB and BCSF barriers has primarily focused on understanding efflux transporters that efficiently prevent drugs from attaining therapeutic concentrations in the CNS. Recently, through the characterization of multiple endogenously expressed uptake transporters, this paradigm has shifted to the study of brain transporter targets that can facilitate drug delivery (i.e., influx transporters). Additionally, signaling pathways and trafficking mechanisms have been identified for several endogenous BBB/BCSF transporters, thereby offering even more opportunities to understand how transporters can be exploited for optimization of CNS drug delivery. This review presents an overview of the BBB and BCSF barrier as well as the many families of transporters functionally expressed at these barrier sites. Furthermore, we present an overview of various strategies that have been designed and utilized to deliver therapeutic agents to the brain with a particular emphasis on those approaches that directly target endogenous BBB/BCSF barrier transporters.

Original languageEnglish (US)
Pages (from-to)1422-1449
Number of pages28
JournalCurrent Pharmaceutical Design
Issue number10
StatePublished - 2014


  • ATP-binding cassette transporters
  • Blood-brain barrier
  • Blood-cerebrospinal fluid barrier
  • Drug delivery
  • Neurovascular unit
  • Solute carriers
  • Transporters

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Transporters at CNS barrier sites: Obstacles or opportunities for drug delivery?'. Together they form a unique fingerprint.

Cite this